New aggressive treatment strategy tested for rare adult sinus cancer
NCT ID NCT07449949
Summary
This study is testing a combination treatment approach for adults with a rare cancer called rhabdomyosarcoma in the nasal cavity and sinuses. The treatment involves chemotherapy, radiation therapy, and surgery in a specific sequence. Researchers want to see how well this approach controls the cancer and improves survival for patients who haven't received previous treatment for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
EENT hospital of Fudan University
Shanghai, China, 200000, China
Conditions
Explore the condition pages connected to this study.